Following up on a pilot study from 2012 (NCT01649921) aiming to investigate the effects of IFN-γ therapy in sepsis [71], investigators from the Radboud University Medical Center are currently recruiting an expected 200 participants for a new multi-center clinical trial with IFN-γ in patients with candidemia (NCT04979052, Table 2). Here, IFNG is linked to Sepsis.